Shanghai, China

Juxi Hao

This inventor holds 1 USPTO granted patent. Top assignee: Abiochem Biotechnology (Group) Co., Ltd.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juxi Hao: Innovator in Biotechnology

Introduction

Juxi Hao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for pharmaceutical applications. His work is characterized by a commitment to advancing scientific knowledge and improving healthcare outcomes.

Latest Patents

Juxi Hao holds a patent for a TRANSAMINASE MUTANT, IMMOBILIZED TRANSAMINASE AND USE IN PREPARATION OF SITAGLIPTIN. This invention showcases his expertise in enzymatic processes and their applications in drug development. The patent reflects his innovative approach to solving complex biochemical challenges.

Career Highlights

Hao is currently employed at Abiochem Biotechnology (Group) Co., Ltd., where he continues to push the boundaries of biotechnological research. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking projects that have the potential to impact the pharmaceutical industry significantly.

Collaborations

Throughout his career, Juxi Hao has worked alongside talented colleagues, including Zhenhua Tian and Zhanbing Cheng. These collaborations have fostered a dynamic research environment that encourages the exchange of ideas and the pursuit of innovative solutions.

Conclusion

Juxi Hao is a dedicated inventor whose work in biotechnology exemplifies the spirit of innovation. His contributions, particularly in the area of transaminase mutants, highlight the importance of research and development in advancing healthcare solutions. His ongoing efforts at Abiochem Biotechnology continue to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…